Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shrinivas Bishu

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Research Square|April 27, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision MakingReid Herran, Samuel Wilcox, Gal Hodish, et al.
Journal of Crohn'S & Colitis|February 5, 2019
CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's DiseaseShrinivas Bishu, Mohammed El Zaatari, Atsushi Hayashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 16, 2025
Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing ColectomyCharlotte Larson, Jeffrey A Berinstein, Nicholas Tedesco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 9, 2025
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: A Multicenter StudyJalpa Devi, Anthony Xu, Molly Stone, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2021
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control StudyJeffrey A Berinstein, Jessica L Sheehan, Michael Dias, et al.
Cell Reports|July 20, 2022
Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restrictionKohei Sugihara, Sho Kitamoto, Prakaimuk Saraithong, et al.
Sleep|May 18, 2018
Rates of cerebral protein synthesis in primary visual cortex during sleep-dependent memory consolidation, a study in human subjectsDante Picchioni, Kathleen C Schmidt, Kelly K McWhirter, et al.
The Journal of Clinical Investigation|March 2, 2021
DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease riskHelmut Grasberger, Andrew T Magis, Elisa Sheng, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 9, 2021
PIR-B Regulates CD4<sup>+</sup> IL17a<sup>+</sup> T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory ResponsesJazib Uddin, Sunil Tomar, Ankit Sharma, et al.
Journal of Crohn'S & Colitis|April 28, 2025
A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn's diseaseAmanda M Johnson, Manar Askar, Seema Belani, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Research Square|April 27, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision MakingReid Herran, Samuel Wilcox, Gal Hodish, et al.
Journal of Crohn'S & Colitis|February 5, 2019
CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's DiseaseShrinivas Bishu, Mohammed El Zaatari, Atsushi Hayashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 16, 2025
Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing ColectomyCharlotte Larson, Jeffrey A Berinstein, Nicholas Tedesco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 9, 2025
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: A Multicenter StudyJalpa Devi, Anthony Xu, Molly Stone, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2021
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control StudyJeffrey A Berinstein, Jessica L Sheehan, Michael Dias, et al.
Cell Reports|July 20, 2022
Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restrictionKohei Sugihara, Sho Kitamoto, Prakaimuk Saraithong, et al.
Sleep|May 18, 2018
Rates of cerebral protein synthesis in primary visual cortex during sleep-dependent memory consolidation, a study in human subjectsDante Picchioni, Kathleen C Schmidt, Kelly K McWhirter, et al.
The Journal of Clinical Investigation|March 2, 2021
DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease riskHelmut Grasberger, Andrew T Magis, Elisa Sheng, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 9, 2021
PIR-B Regulates CD4<sup>+</sup> IL17a<sup>+</sup> T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory ResponsesJazib Uddin, Sunil Tomar, Ankit Sharma, et al.
Journal of Crohn'S & Colitis|April 28, 2025
A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn's diseaseAmanda M Johnson, Manar Askar, Seema Belani, et al.
Pageof 9